Within days to weeks of stopping treatment, patients generally experience return of appetite to pre-treatment levels, faster gastric emptying, and loss of the medication's effects on satiety signaling
There are no further patents, products in development or marketed products to declare
To shed light on these questions, Sam West, a postdoctoral researcher at the University of Oxford and his co-authors reviewed randomized trials and observational studies on more than 6,000 adults who were overweight or obese and took GLP-1s or older weight-loss medications compared with 3,000 others in behavioural weight management programs
Alpha-Lipoic Acid (ALA) - Can increase glucose uptake, compounding hypoglycemia risk
Biochem J 210:899903 Lelarge-Trouverie C, Cohen M, Trmulot L, Van Breusegem F, Mhamdi A, Noctor G (2023) Metabolite modification in oxidative stress responses: a case study of two defense hormones